The global opioids agonist drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are fuelling the growth of the market include the growing prevalence of pain and diarrhea. Opioids are generally used for treating pain, however, opioid-containing drugs are being misused or are being consumed in overdose when patients follow self-medication. The opioid drug class comprises morphine, hydrocodone, oxycodone, heroin, codeine, morphine, fentanyl, and methadone. It is also employed as a cough suppressant and in diarrhea treatment. Opioids can be administered either through pills, liquids, intravenous, transdermal patches, or lozenges. Developed nations in North America and Europe have high levels of abuse of this drug. Drugs such as codeine, morphine, fentanyl, and hydrocodone have become a source of addiction, especially among the population, owing to the easy availability of drugs in these regions.
To Request a Sample of our Report on Global Opioids Agonist Drugs Market: https://www.omrglobal.com/request-sample/opioids-agonist-drugs-market
However, global organisations as well as regulatory agencies including the FDA, Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) are working towards restricting the abuse of opioids by creating awareness and educating prescribers to be cautious while prescribing these drugs. In 2016, the CDC issued guidelines to prescribe opioids, limiting the daily dose of opioids to 90 morphine milligram equivalent (MME). In recent years, cannabis has emerged as an alternative for opioids. Cannabis is legalized in many states in the US, as it is considered safer than opioids. Therefore, legalizing cannabis (marijuana) is a factor that is expected to have a detrimental impact on the market growth during the forecast period.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: Pfizer Inc., Boehringer Ingelheim GmbH, and Sanofi S.A., among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Opioids Agonist Drugs Market is Available at: https://www.omrglobal.com/industry-reports/opioids-agonist-drugs-market
Global Opioids Agonist Drugs Market Report by Segment
By Product
• Codeine
• Fentanyl
• Meperidine
• Methadone
• Others
By Application
• Pain Management
• Cough Treatment
• Diarrhea Treatment
Global Opioids Agonist Drugs Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
